The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones

被引:19
|
作者
Straiker, Alex [1 ]
Wager-Miller, Jim [1 ]
Mackie, Ken [1 ]
机构
[1] Indiana Univ, Dept Psychol & Brain Sci, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA
基金
美国国家卫生研究院;
关键词
endocannabinoid; DSE; 2-AG; retrograde transmission; PROTEIN-COUPLED RECEPTORS; RAT-BRAIN; INTERNALIZATION; DELTA(9)-TETRAHYDROCANNABINOL; SUPPRESSION; AGONIST; CELLS; PHARMACOLOGY; INHIBITION; EXCITATION;
D O I
10.1111/j.1476-5381.2011.01743.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND AND PURPOSE The cannabinoid CB1 receptor is the chief mediator of the CNS effects of cannabinoids. In cell culture model systems, CB1 receptors both desensitize and internalize on activation. Previous work suggests that the extreme carboxy-terminus of this receptor regulates internalization via phosphorylation of residues clustered within this region. Mutational analysis of the carboxy-terminus of CB1 receptors has demonstrated that the last six serine/threonine residues are necessary for agonist-induced internalization. However, the structural determinants of CB1 receptor internalization are also dependent on the local cellular environment. The importance of cell context on CB1 receptor function calls for an investigation of the functional roles of these residues in neurones. EXPERIMENTAL APPROACH To determine the structural requirements of CB1 internalization in neurones, we evaluated the signalling properties of carboxyterminal mutated CB1 receptors expressed in cultured autaptic hippocampal neurones, using electrophysiological methods. KEY RESULTS CB1 receptors transfected into CB1 knockout neurones signalled and desensitized as did wild-type neurones, allowing us to test specific CB1 receptor mutations. Deletion of the last 13 residues yielded a CB1 receptor that inhibited excitatory postsynaptic currents but did not desensitize. Furthermore, mutation of the final six serine and threonine residues to alanines resulted in a non-desensitizing receptor. In contrast, CB1 receptors lacking residues 419-460, leaving the last 14 residues intact, did desensitize. CONCLUSIONS AND IMPLICATIONS The distal thirteen residues of CB1 receptors are crucial for their desensitization in cultured neurones. Furthermore, this desensitization is likely to follow phosphorylation of serines and threonines within this region.
引用
收藏
页码:2652 / 2659
页数:8
相关论文
共 50 条
  • [41] Fmr1 deletion enhances and ultimately desensitizes CB1 signaling in autaptic hippocampal neurons
    Straiker, Alex
    Min, Kyung-Tai
    Mackie, Ken
    NEUROBIOLOGY OF DISEASE, 2013, 56 : 1 - 5
  • [42] CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice
    Watkins, Joshua
    Aradi, Petra
    Hahn, Rachel
    Makriyannis, Alexandros
    Mackie, Ken
    Katona, Istvan
    Hohmann, Andrea G.
    PHARMACOLOGICAL RESEARCH, 2025, 214
  • [43] Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor
    Horvath, Viktoria B.
    Soltesz-Katona, Eszter
    Wisniewski, Eva
    Rajki, Aniko
    Halasz, Eszter
    Enyedi, Balazs
    Hunyady, Laszlo
    Toth, Andras David
    Szanda, Gergo
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [44] Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
    Ward, Richard J.
    Pediani, John D.
    Milligan, Graeme
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (43) : 37414 - 37428
  • [45] Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor
    Yano, Hideaki
    Chitsazi, Rezvan
    Lucaj, Christopher
    Tran, Phuong
    Hoffman, Alexander F.
    Baumann, Michael H.
    Lupica, Carl R.
    Shi, Lei
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (21): : 3928 - 3940
  • [46] Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice
    Baireddy, Praveena
    Liu, Jing
    Hinsdale, Myron
    Pope, Carey
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 256 (03) : 324 - 329
  • [47] Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
    Smith, Tricia H.
    Blume, Lawrence C.
    Straiker, Alex
    Cox, Jordan O.
    David, Bethany G.
    Mcvoy, Julie R. Secor
    Sayers, Katherine W.
    Poklis, Justin L.
    Abdullah, Rehab A.
    Egertova, Michaela
    Chen, Ching-Kang
    Mackie, Ken
    Elphick, Maurice R.
    Howlett, Allyn C.
    Selley, Dana E.
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 747 - 765
  • [48] Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling
    Daigle, Tanya L.
    Kearn, Christopher S.
    Mackie, Ken
    NEUROPHARMACOLOGY, 2008, 54 (01) : 36 - 44
  • [49] Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
    Pacheco, Daniela da Fonseca
    Klein, Andre
    Perez, Andrea Castro
    da Fonseca Pacheco, Cinthia Mara
    de Francischi, Janetti Nogueira
    Lopes Reis, Glaucia Maria
    Gama Duarte, Igor Dimitri
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 225 - 231
  • [50] Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
    Blume, Lawrence C.
    Patten, Theresa
    Eldeeb, Khalil
    Leone-Kabler, Sandra
    Ilyasov, Alexander A.
    Keegan, Bradley M.
    O'Neal, Jeremy E.
    Bass, Caroline E.
    Hantgan, Roy R.
    Lowther, W. Todd
    Selley, Dana E.
    Howlett, Allyn C.
    MOLECULAR PHARMACOLOGY, 2017, 91 (02) : 75 - 86